Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

This study is tracking the outcomes of patients with mild glaucoma who have a small drainage device called a Hydrus Microstent implanted during routine cataract surgery. The goal is to see how well this minimally invasive procedure lowers eye pressure over time and reduces the need for glaucoma eye drops. **You may be eligible if...** - You are 45 or older with a visually significant cataract in both eyes - You have mild, stable open-angle glaucoma (a type affecting the drainage channels of the eye) - Your eye pressure is controlled on 1–3 glaucoma medications - Your glaucoma has been stable for at least 1 year - You are scheduled for cataract surgery **You may NOT be eligible if...** - You have had prior glaucoma surgery or laser treatment within 90 days - You have a more aggressive type of glaucoma (angle-closure, pseudoexfoliative, traumatic, neovascular) - You have moderate or severe glaucoma with significant vision field loss - You have other eye problems that could affect vision (like macular degeneration or significant corneal scarring) - You are pregnant or breastfeeding - You have had prior refractive surgery (LASIK, PRK, etc.) Talk to your doctor to see if this trial is right for you.